Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CIMIP2B | Human | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of CIMIP2B mRNA | CTD | PMID:30851411 | CIMIP2B | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Cimip2b (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of CIMIP2B mRNA | CTD | PMID:36843608 | CIMIP2B | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of CIMIP2B intron | CTD | PMID:30157460 | CIMIP2B | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of CIMIP2B promoter | CTD | PMID:27901495 | CIMIP2B | Human | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [AHR gene mutant form affects the susceptibility to Benzo(a)pyrene] which results in decreased expression of FAM166B mRNA | CTD | PMID:38036013 | CIMIP2B | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of CIMIP2B 5' UTR | CTD | PMID:27901495 | CIMIP2B | Human | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of CIMIP2B mRNA | CTD | PMID:31163220 | CIMIP2B | Human | bisphenol F | decreases expression | ISO | Cimip2b (Mus musculus) | 6480464 | bisphenol F results in decreased expression of CIMIP2B mRNA | CTD | PMID:38685157 | CIMIP2B | Human | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of CIMIP2B mRNA | CTD | PMID:26079696 | CIMIP2B | Human | carbon nanotube | decreases expression | ISO | Cimip2b (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CIMIP2B | Human | dibenz[a,h]anthracene | decreases expression | ISO | Cimip2b (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | CIMIP2B | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CIMIP2B mRNA | CTD | PMID:27188386 | CIMIP2B | Human | ozone | decreases expression | ISO | Cimip2b (Mus musculus) | 6480464 | Ozone results in decreased expression of FAM166B mRNA | CTD | PMID:33026818 | CIMIP2B | Human | pentanal | increases expression | EXP | | 6480464 | pentanal results in increased expression of CIMIP2B mRNA | CTD | PMID:26079696 | CIMIP2B | Human | pirinixic acid | increases expression | ISO | Cimip2b (Mus musculus) | 6480464 | pirinixic acid results in increased expression of CIMIP2B mRNA | CTD | PMID:20813756 | CIMIP2B | Human | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of CIMIP2B mRNA | CTD | PMID:30851411 | CIMIP2B | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CIMIP2B mRNA | CTD | PMID:27188386 | CIMIP2B | Human | titanium dioxide | affects expression | ISO | Cimip2b (Mus musculus) | 6480464 | titanium dioxide affects the expression of CIMIP2B mRNA | CTD | PMID:23557971 | CIMIP2B | Human | titanium dioxide | decreases expression | ISO | Cimip2b (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of CIMIP2B mRNA | CTD | PMID:35295148 | CIMIP2B | Human | torcetrapib | increases expression | EXP | | 6480464 | torcetrapib results in increased expression of CIMIP2B mRNA | CTD | PMID:23228038 | CIMIP2B | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of CIMIP2B gene | CTD | PMID:29154799 | CIMIP2B | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CIMIP2B mRNA | CTD | PMID:23179753 and PMID:26272509 | CIMIP2B | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CIMIP2B mRNA | CTD | PMID:27188386 | |